Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ExPRESSION: Endotypes and Response in OSA Patients
NCT04875364Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- Aug 2020
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eszopiclone in obstructive sleep apnea (OSA), sponsored by University of California, San Diego. Started Aug 2020; status: completed.
02
Drugs
eszopiclone
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT04875364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04875364.